(S)-tert-Butyl 2-propylpiperazine-1-carboxylate

Catalog No. :
ACCRZJ923
CAS No. :
888972-67-6
Molecular Formula :
C12H24N2O2
Molecular Weight :
228.34

IUPAC Name:tert-butyl (S)-2-propylpiperazine-1-carboxylate

(S)-tert-Butyl 2-propylpiperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$92.00Login to see priceIn stockInquiry
5g98%$332.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 2-propylpiperazine-1-carboxylate
IUPAC Nametert-butyl (S)-2-propylpiperazine-1-carboxylate
MDL No.MFCD07772097
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESCCC[C@@H]1N(C(OC(C)(C)C)=O)CCNC1
InChI KeyPYTGOQORCFQPSZ-JTQLQIEISA-N
Synonym(S)-1-N-BOC-2-N-PROPYLPIPERAZINE;(S)-1-N-BOC-2-PROPYL PIPERAZINE;(S)-2-PROPYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;(S)-1-Boc-2-propylpiperazine;(2S)-1-N-BOC-2-PROPYLPIPERAZINE;(S)-1-Boc -2-propyl-piperazine HCl;(R)-tert-butyl 3-propylpiperazine-1-carboxylate;(S)-1-Boc-2-propylpiperazine ,98%
CAS No.888972-67-6
PubChem CID44593842

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCRZJ923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACCRZJ923 route product structure diagram
    ACCRZJ923888972-67-6 In Stock
Inquiry

2. ACCRZJ923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCRZJ923 route product structure diagram
    ACCRZJ923888972-67-6 In Stock
Inquiry

Comments (0)